ELI LILLY & Co is 3.7x more valuable than Merck & Co., Inc. by market capitalization ($1.072 T vs $293.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRK | LLY |
|---|---|---|
| Market cap | $293.16 B | $1.072 T |
| US-listed rank | #44 | #10 |
| Revenue (latest FY) | $65.01B | $65.18B |
| Net income (latest FY) | $18.25B | $20.64B |
| Net margin | 28.1% | 31.7% |
| P/E (trailing FY) | 16.1 | 51.9 |
| SEC filings | 996 | 989 |
ELI LILLY & Co is 3.7x more valuable than Merck & Co., Inc. by market capitalization ($1.072 T vs $293.16 B).
In their latest fiscal years, Merck & Co., Inc. reported $65.01B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Merck & Co., Inc. and ELI LILLY & Co, or browse the full rankings.